V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004569 | 330007220 | 1.52 | null | Palliative (P) | 2014-10-03 | 2014-10-03 | CISPLATIN + FLUOROURACIL + RT | N | N | 330018940 | RUXOLITINIB |
| 330004570 | 330002211 | null | 102 | Palliative (P) | 2017-02-06 | 2017-03-07 | Doxorubicin + Olaratumab | Y | N | 330018945 | CHLORAMBUCIL + RITUXIMAB |
| 330004571 | 330002211 | 1.86 | null | Palliative (P) | 2018-01-31 | 2018-02-13 | CNS LGG 2004 03 vinc weekly+ carbo | null | N | 330018945 | EPIRUBICIN |
| 330004572 | 330002211 | 1.81 | 91.1 | Disease modification (D) | 2017-08-24 | 2017-08-24 | Cetuximab +Cisplatin + FU (Cycle 1) | Y | Y | 330018945 | CARBOPLATIN + RT |
| 330004573 | 330002211 | 1.53 | 63.8 | Curative (C) | 2015-11-17 | 2015-11-20 | PEMBROLIZUMAB | N | N | 330018945 | TRASTUZUMAB |
| 330004574 | 330002211 | 1.72 | 107.9 | Curative (C) | 2015-04-15 | 2015-05-11 | Capecitabine + Cisplatin | N | N | 330018945 | CARBOPLATIN + VINCRISTINE |
| 330004575 | 330002212 | null | null | Curative (C) | 2018-02-26 | 2018-02-26 | GC Int Guide Excranial GermCell JEB | null | N | 330018966 | BEP |
| 330004576 | 330002212 | 0 | 76.9 | Curative (C) | 2018-08-15 | 2018-08-16 | METHOTREXATE | 1 | N | 330018966 | DOCETAXEL + GEMCITABINE |
| 330004577 | 330002213 | 1.56 | 70 | Palliative (P) | 2016-08-05 | 2016-08-05 | Ifosfamide PVI 1g/m2 14day | null | null | 330018981 | PALBOCICLIB |
| 330004578 | 330007223 | 0 | 60.3 | Palliative (P) | 2015-02-09 | 2015-02-14 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 330018989 | CISPLATIN + DOX + ETOPOSIDE |
| 330004579 | 330007223 | null | 79.2 | null | 2015-02-28 | 2015-03-03 | ETOPOSIDE | 02 | N | 330018989 | CISPLATIN + FLUOROURACIL + GEMCITABINE |
| 330004580 | 330002214 | 1.57 | 76 | Palliative (P) | 2016-05-07 | 2016-05-25 | PCV | 1 | N | 330018993 | CHOP |
| 330004581 | 330007224 | 1.76 | 60 | Curative (C) | 2016-04-13 | 2016-04-22 | Capecitabine | N | null | 330019009 | ETOPOSIDE + IFOSFAMIDE |
| 330004582 | 330007224 | null | 79 | null | 2017-07-20 | 2017-08-03 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | null | 330019009 | IMATINIB |
| 330004583 | 330007224 | 1.74 | 42 | Palliative (P) | 2017-03-28 | 2017-04-02 | Etoposide + Ifosfamide (3 days) | N | N | 330019009 | DACTINOMYCIN |
| 330004584 | 330002215 | 1.61 | 69.9 | Palliative (P) | null | 2016-03-02 | ETOPOSIDE + IFOSFAMIDE | N | N | 330019017 | IRINOTECAN + TEMOZOLOMIDE |
| 330004585 | 330002216 | 1.83 | 134 | Palliative (P) | 2018-01-21 | 2018-01-30 | Azacitidine | N | N | 330019024 | ETOPOSIDE + RITUXIMAB |
| 330004586 | 330002216 | null | null | Curative (C) | 2015-03-14 | 2015-03-23 | ECX | N | N | 330019024 | VINCRISTINE |
| 330004587 | 330002217 | null | 113.2 | Curative (C) | null | 2014-11-15 | Carboplatin + Doxorubicin | null | null | 330019042 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 330004588 | 330002217 | 1.75 | 84.7 | Curative (C) | 2014-10-11 | 2014-10-17 | Packer Induction Vincristine + RT | 02 | N | 330019042 | DACARBAZINE |
| 330004589 | 330002218 | 1.56 | 79.9 | Curative (C) | 2016-05-13 | 2016-05-13 | ATG + Busulfan + Fludarabine | 2 | N | 330019077 | CHLORAMBUCIL + RITUXIMAB |
| 330004590 | 330002219 | null | null | Disease modification (D) | null | 2017-02-21 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | null | null | 330019078 | ETOPOSIDE + IFOSFAMIDE |
| 330004591 | 330007227 | null | 83.6 | Palliative (P) | 2013-05-13 | 2013-06-01 | Oxaliplatin + Modified de Gramont | N | N | 330019079 | PACLITAXEL |
| 330004592 | 330002220 | 1.56 | 54 | Curative (C) | 2015-05-31 | 2016-01-04 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 330019083 | VIDE |
| 330004593 | 330007228 | 1.69 | 80 | Palliative (P) | 2016-02-04 | 2016-02-04 | FLAG + Idarubicin | N | N | 330019085 | FLAG |
| 330004594 | 330007228 | 1.68 | 86.5 | Palliative (P) | 2015-02-26 | 2015-02-27 | CARBOPLATIN + RT | Y | N | 330019085 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 330004595 | 330007228 | null | 56.4 | Palliative (P) | 2013-07-28 | 2013-08-03 | FLAG + Idarubicin | N | N | 330019085 | CISPLATIN + FLUOROURACIL + RT |
| 330004596 | 330007228 | null | null | null | null | 2015-02-13 | Cisplatin + Pemetrexed | null | null | 330019085 | RUXOLITINIB |
| 330004597 | 330007228 | 1.6 | 95.1 | Curative (C) | 2016-05-26 | 2016-05-27 | Hydroxycarbamide | 02 | N | 330019085 | METHOTREXATE HIGH DOSE |
| 330004598 | 330007228 | 1.67 | 64.1 | Curative (C) | 2016-10-04 | 2016-10-07 | Methotrexate + Folinic acid | N | N | 330019085 | CISPLATIN + DOXORUBICIN + METHOTREXATE |
| 330004599 | 330007228 | 1.64 | 19.7 | Disease modification (D) | 2015-11-08 | 2015-11-23 | FLAG + Idarubicin | null | null | 330019085 | AZACITIDINE |
| 330004600 | 330002221 | 1.9 | 66 | Curative (C) | 2015-09-01 | 2015-09-01 | CTD Attenuated (Thalidomide 50mg) | 02 | N | 330019124 | IMATINIB |
| 330004601 | 330002221 | 1.77 | 58.8 | Palliative (P) | 2015-05-04 | 2015-05-04 | UKALL XII Induction Phase 1 | N | N | 330019124 | HYDROXYCARBAMIDE |
| 330004602 | 330002222 | 1.8 | 134 | Curative (C) | 2015-12-16 | 2015-12-21 | Cyclophosphamide oral | 02 | N | 330019139 | CHLORAMBUCIL + RITUXIMAB |
| 330004603 | 330002223 | 1.85 | null | Palliative (P) | 2017-06-20 | 2017-06-20 | BEP 5 Day | N | N | 330019167 | AML19 TRIAL |
| 330004604 | 330007230 | 1.76 | 82.5 | Disease modification (D) | 2013-02-17 | 2013-02-17 | Vemurafenib | 02 | N | 330019174 | UKALL2011 |
| 330004605 | 330007230 | 1.69 | 61.4 | Curative (C) | 2016-07-08 | 2016-07-11 | VIDE | Y | N | 330019174 | CYTARABINE |
| 330004606 | 330002224 | 1.74 | 73.2 | Curative (C) | 2015-07-29 | 2015-07-29 | CVP | N | N | 330019202 | CISPLATIN + CYCLO + DOXORUBICIN |
| 330004607 | 330002225 | 1.63 | 71.6 | Palliative (P) | 2016-10-20 | 2016-10-20 | Docetaxel + Gemcitabine with GCSF | 02 | Y | 330019205 | METHOTREXATE HIGH DOSE |
| 330004612 | 330002226 | 1.85 | 83.6 | Curative (C) | 2013-11-22 | 2013-12-05 | Cisplatin + Pemetrexed | N | N | 330019273 | UKALL 2011 |
| 330004613 | 330007232 | 1.76 | 74 | Disease modification (D) | null | 2017-10-20 | Melphalan IV High dose | N | N | 330019278 | CARBOPLATIN + RT |
| 330004614 | 330002227 | 1.8 | 41.7 | Curative (C) | 2016-09-11 | 2016-09-19 | FLUOROURACIL + OXALIPLATIN | N | N | 330019291 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004615 | 330002227 | null | 59.3 | Curative (C) | 2014-08-09 | 2014-08-11 | FLAG + Idarubicin | N | Y | 330019291 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 330004616 | 330002228 | 1.54 | 80.4 | Palliative (P) | 2014-08-01 | 2014-08-07 | Chlorambucil | 02 | null | 330019316 | OXALIPLATIN + MDG |
| 330004617 | 330002229 | 1.8 | 73 | Curative (C) | 2017-08-15 | 2017-08-27 | Ipilimumab | Y | N | 330019319 | TCF |
| 330004618 | 330002229 | null | 109.5 | Curative (C) | 2017-07-20 | 2017-07-31 | Bendamustine + prednisolone | N | N | 330019319 | TOPOTECAN |
| 330004619 | 330002229 | null | null | Palliative (P) | 2017-05-23 | 2017-07-02 | GC Int Guide Excranial GermCell JEB | N | Y | 330019319 | CLADRIBINE |
| 330004620 | 330002230 | 1.77 | 30.4 | Curative (C) | 2015-08-17 | 2015-08-27 | FCR Oral - Cycle 1 | N | N | 330019333 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330004621 | 330002231 | 1.68 | 57 | Adjuvant (A) | 2013-09-12 | 2013-09-23 | PEI | 02 | N | 330019340 | CAPECITABINE + OXALIPLATIN |
| 330004622 | 330002231 | 1.93 | 94.1 | Palliative (P) | 2015-03-04 | 2015-03-04 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | null | 330019340 | CAPE + CARBOPLATIN + CETUXIMAB |